44 related articles for article (PubMed ID: 38720884)
1. Exploiting tertiary lymphoid structures gene signature to evaluate tumor microenvironment infiltration and immunotherapy response in colorectal cancer.
Xu Z; Wang Q; Zhang Y; Li X; Wang M; Zhang Y; Pei Y; Li K; Yang M; Luo L; Wu C; Wang W
Front Oncol; 2024; 14():1383096. PubMed ID: 38846981
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy in Sarcoma: Current Data and Promising Strategies.
Wood GE; Meyer C; Petitprez F; D'Angelo SP
Am Soc Clin Oncol Educ Book; 2024 Jun; 44(3):e432234. PubMed ID: 38781557
[TBL] [Abstract][Full Text] [Related]
3. Integrative analysis of single-cell and bulk RNA sequencing unveils a machine learning-based pan-cancer major histocompatibility complex-related signature for predicting immunotherapy efficacy.
Feng JL; Liang B; Zheng WJ; Xu L; Zhou QY; Chen J
Cancer Immunol Immunother; 2024 May; 73(7):121. PubMed ID: 38714579
[TBL] [Abstract][Full Text] [Related]
4. Genomic Insights into the Role of TOP Gene Family in Soft-Tissue Sarcomas: Implications for Prognosis and Therapy.
Wang G; Gan X; Chen X; Zeng Q; Zhang Z; Li J; Guo Z; Hou LC; Xu J; Kang H; Guo F
Adv Biol (Weinh); 2024 Jun; ():e2300678. PubMed ID: 38837283
[TBL] [Abstract][Full Text] [Related]
5. Identifying specific TLS-associated genes as potential biomarkers for predicting prognosis and evaluating the efficacy of immunotherapy in soft tissue sarcoma.
Wang XX; Liu YP; Lu Y; Wu LH; Ren JY; Ji H; Wang X; Zhang HM
Front Immunol; 2024; 15():1372692. PubMed ID: 38720884
[TBL] [Abstract][Full Text] [Related]
6. Nanotechnology Reprogramming Metabolism for Enhanced Tumor Immunotherapy.
Zhou Y; Yuan J; Xu K; Li S; Liu Y
ACS Nano; 2024 Jan; 18(3):1846-1864. PubMed ID: 38180952
[TBL] [Abstract][Full Text] [Related]
7. Immune Cells in the Tumor Microenvironment of Soft Tissue Sarcomas.
Jumaniyazova E; Lokhonina A; Dzhalilova D; Kosyreva A; Fatkhudinov T
Cancers (Basel); 2023 Dec; 15(24):. PubMed ID: 38136307
[TBL] [Abstract][Full Text] [Related]
8. Dual-specificity phosphatase 1 inhibits Singapore grouper iridovirus replication via regulating apoptosis in Epinephelus coioides.
He JY; Cai YJ; Li YX; Huang W; Zhang Y; Liu KJ; Sun Z; Dai LL; Qin QW; Sun HY
Fish Shellfish Immunol; 2024 Feb; 145():109313. PubMed ID: 38128678
[TBL] [Abstract][Full Text] [Related]
9. A Large-Scale Meta-Analysis Reveals Positive Feedback between Macrophages and T Cells That Sensitizes Tumors to Immunotherapy.
Yang J; Liu Q; Shyr Y
Cancer Res; 2024 Feb; 84(4):626-638. PubMed ID: 38117502
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy combination approaches: mechanisms, biomarkers and clinical observations.
Butterfield LH; Najjar YG
Nat Rev Immunol; 2024 Jun; 24(6):399-416. PubMed ID: 38057451
[TBL] [Abstract][Full Text] [Related]
11. Soft Tissue Sarcomas in Adolescents and Young Adults.
Weiss AR; Harrison DJ
J Clin Oncol; 2024 Feb; 42(6):675-685. PubMed ID: 37967293
[TBL] [Abstract][Full Text] [Related]
12. Computational immunogenomic approaches to predict response to cancer immunotherapies.
Addala V; Newell F; Pearson JV; Redwood A; Robinson BW; Creaney J; Waddell N
Nat Rev Clin Oncol; 2024 Jan; 21(1):28-46. PubMed ID: 37907723
[TBL] [Abstract][Full Text] [Related]
13. TNFSF14/LIGHT promotes cardiac fibrosis and atrial fibrillation vulnerability via PI3Kγ/SGK1 pathway-dependent M2 macrophage polarisation.
Wu Y; Zhan S; Chen L; Sun M; Li M; Mou X; Zhang Z; Xu L; Xu Y
J Transl Med; 2023 Aug; 21(1):544. PubMed ID: 37580750
[TBL] [Abstract][Full Text] [Related]
14. LIGHT/TNFSF14 promotes CAR-T cell trafficking and cytotoxicity through reversing immunosuppressive tumor microenvironment.
Zhang N; Liu X; Qin J; Sun Y; Xiong H; Lin B; Liu K; Tan B; Zhang C; Huang C; Ren S; Liu M; Du B
Mol Ther; 2023 Sep; 31(9):2575-2590. PubMed ID: 37408308
[TBL] [Abstract][Full Text] [Related]
15. Tailoring vascular phenotype through AAV therapy promotes anti-tumor immunity in glioma.
Ramachandran M; Vaccaro A; van de Walle T; Georganaki M; Lugano R; Vemuri K; Kourougkiaouri D; Vazaios K; Hedlund M; Tsaridou G; Uhrbom L; Pietilä I; Martikainen M; van Hooren L; Olsson Bontell T; Jakola AS; Yu D; Westermark B; Essand M; Dimberg A
Cancer Cell; 2023 Jun; 41(6):1134-1151.e10. PubMed ID: 37172581
[TBL] [Abstract][Full Text] [Related]
16. DUSP9 alleviates hepatic ischemia/reperfusion injury by restraining both mitogen-activated protein kinase and IKK in an apoptosis signal-regulating kinase 1-dependent manner.
Li Z; Huang Z; Luo Y; Yang H; Yang M
Acta Biochim Biophys Sin (Shanghai); 2022 Dec; 54(12):1811-1821. PubMed ID: 36789693
[TBL] [Abstract][Full Text] [Related]
17. Cancer statistics, 2023.
Siegel RL; Miller KD; Wagle NS; Jemal A
CA Cancer J Clin; 2023 Jan; 73(1):17-48. PubMed ID: 36633525
[TBL] [Abstract][Full Text] [Related]
18. The Role of Interleukin-7 in the Formation of Tertiary Lymphoid Structures and Their Prognostic Value in Gastrointestinal Cancers.
Ware MB; Wolfarth AA; Goon JB; Ezeanya UI; Dhar S; Ferrando-Martinez S; Lee BH
J Immunother Precis Oncol; 2022 Nov; 5(4):105-117. PubMed ID: 36483588
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
